Literature DB >> 16320247

Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.

Nicole C Christacos1, Bradley J Quade, Paola Dal Cin, Cynthia C Morton.   

Abstract

Cytogenetic analysis of uterine leiomyomata (UL) shows that about 40% of these benign tumors have simple, clonal chromosomal rearrangements. In contrast, their presumed malignant counterpart, leiomyosarcomas (LMSs), typically has complex numerical and structural abnormalities. Several variants of benign uterine smooth-muscle tumors are defined by histologic phenotypes intermediate between typical UL and LMS, and currently, little is known about their cytogenetic and molecular genetic features. From a subset of more than 800 karyotyped ULs, we identified a group of nine cases exhibiting near-diploid karyotypes with loss of almost the entire short (p) arm of chromosome 1 [i.e., del(1)(p11p36)]. Loss of 1p was often associated with other aberrations, particularly loss of chromosomes 19 and/or 22. Of eight UL for which the histologic diagnosis was known, four were diagnosed as cellular UL; one displayed both hypercellularity and nuclear atypia. Loss of heterozygosity (LOH) analysis for chromosomal regions 1p36.23 and 1p21.1 demonstrated allelic loss for either a portion or the majority of 1p in 5 of 10 additional archival UL diagnosed with either cellular or atypical histology. RNA from two UL with loss of 1p was profiled using Affymetrix GeneChips, and those profiles were compared to our previously reported smooth-muscle tumor expression profile. The transcriptional profiles of tumors with 1p deletion were more similar to those of leiomyosarcoma than to profiles of myometrium and UL, as determined by hierarchical cluster analysis. Comparison of the transcriptional profiles for UL with and without 1p-- revealed 53 genes with differential regulation. Loss of 1p appears to define a subgroup of UL distinct from those previously recognized. Furthermore, 1p-- appears to be associated with a specific histologic phenotype. The similarity between the transcriptional profiles of LMS and UL with 1p-- suggests the possibility of a common pathogenetic mechanism.

Entities:  

Mesh:

Year:  2006        PMID: 16320247     DOI: 10.1002/gcc.20291

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  23 in total

1.  Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity.

Authors:  Jennelle C Hodge; Kathryn E Pearce; Amy C Clayton; Florin A Taran; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2014-01-08       Impact factor: 8.661

Review 2.  Fibroids: Genotype and Phenotype.

Authors:  Zehra Ordulu
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

3.  Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis.

Authors:  Joslin M Bowen; Justin M Cates; Shera Kash; Doha Itani; Adriana Gonzalez; Dali Huang; Andre Oliveira; Julia A Bridge
Journal:  Cancer Genet       Date:  2012-05

4.  Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma.

Authors:  Jasmine H Francis; Ruth A Kleinerman; Johanna M Seddon; David H Abramson
Journal:  Gynecol Oncol       Date:  2011-10-23       Impact factor: 5.482

5.  Magnetic resonance elastography of uterine leiomyomas: a feasibility study.

Authors:  Elizabeth A Stewart; F Andrei Taran; Jun Chen; Bobbie S Gostout; David A Woodrum; Joel P Felmlee; Richard L Ehman
Journal:  Fertil Steril       Date:  2010-07-15       Impact factor: 7.329

6.  Fumarate Hydratase Mutations and Alterations in Leiomyoma With Bizarre Nuclei.

Authors:  Qing Zhang; Kate Poropatich; Julianne Ubago; Jia Xie; Xiuhua Xu; Norma Frizzell; Julie Kim; Beihua Kong; Jian-Jun Wei
Journal:  Int J Gynecol Pathol       Date:  2018-09       Impact factor: 2.762

7.  Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata.

Authors:  Stacey L Eggert; Karen L Huyck; Priya Somasundaram; Raghava Kavalla; Elizabeth A Stewart; Ake T Lu; Jodie N Painter; Grant W Montgomery; Sarah E Medland; Dale R Nyholt; Susan A Treloar; Krina T Zondervan; Andrew C Heath; Pamela A F Madden; Lynda Rose; Julie E Buring; Paul M Ridker; Daniel I Chasman; Nicholas G Martin; Rita M Cantor; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2012-10-05       Impact factor: 11.025

8.  Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.

Authors:  Bernadette Liegl-Atzwanger; Ellen Heitzer; Karin Flicker; Stephanie Müller; Peter Ulz; Ozlen Saglam; Fattaneh Tavassoli; Mojgan Devouassoux-Shisheboran; Jochen Geigl; Farid Moinfar
Journal:  Mod Pathol       Date:  2016-07-01       Impact factor: 7.842

9.  Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.

Authors:  Jennelle C Hodge; Bradley J Quade; Mark A Rubin; Elizabeth A Stewart; Paola Dal Cin; Cynthia C Morton
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

Review 10.  [Update on gynecopathology].

Authors:  D Schmidt
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.